Literature DB >> 20101382

The time has come for incretins, a long time coming.

Friedrich C Luft1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20101382     DOI： 10.1007/s00109-009-0586-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  14 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.

Authors:  F Rodriquez de Fonseca; M Navarro; E Alvarez; I Roncero; J A Chowen; O Maestre; R Gómez; R M Muñoz; J Eng; E Blázquez
Journal:  Metabolism       Date:  2000-06       Impact factor: 8.694

3.  The discovery of glucagon-like peptide 1.

Authors:  P Kay Lund
Journal:  Regul Pept       Date:  2005-06-15

Review 4.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

Authors:  Daniel J Drucker; Michael A Nauck
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

5.  Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.

Authors:  Meng-Ju Liu; Seungjin Shin; Na Li; Toshikatsu Shigihara; Young-Sun Lee; Ji-Won Yoon; Hee-Sook Jun
Journal:  Mol Ther       Date:  2007-01       Impact factor: 11.454

6.  Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.

Authors:  S A Ross; J C Brown; J Dupré
Journal:  Diabetes       Date:  1977-06       Impact factor: 9.461

7.  Treatment of diabetes by transplantation of drug-inducible insulin-producing gut cells.

Authors:  Suraj Unniappan; Rhonda D Wideman; Christine Donald; Virginia Gunn; Jennifer L Wall; Qiu-Xia Zhang; Travis D Webber; Anthony T Cheung; Timothy J Kieffer
Journal:  J Mol Med (Berl)       Date:  2009-04-23       Impact factor: 4.599

8.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

9.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

10.  Hamster preproglucagon contains the sequence of glucagon and two related peptides.

Authors:  G I Bell; R F Santerre; G T Mullenbach
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.